We speculate that apart from suppressing IDO1 expression and function, carbidopa serve to inhibit tryptophan entry into tumor cells and tumor-associated immune cells by blocking either the Tryptophan-selective transporter [54] or other amino acid transporters such as SLC6A14 that transport Tryptophan. The gene discussed is SLC38A7; the disease is neoplasm.